Literature DB >> 738354

Effects of pimozide on the response of smooth muscle to non-dopamine agonists and calcium.

A Quintana.   

Abstract

Pimozide inhibits acetylcholine and histamine-induced contractions of the isolated guinea-pig ileum and noradrenaline-induced contractions of the isolated rat vas deferens in a non-competitive manner. In order to explore the nature of this inhibitory effect, we investigated pimozide's effects on calcium-induced contractions of deplorized guinea-pig ileum. In this case the antagonism elicited was competitive. Therefore caution is indicated in the use of pimozide to provide indirect proof of the existence of peripheral dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 738354     DOI: 10.1016/0014-2999(78)90274-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Analysis of the effects of dopamine and noradrenaline in relation to the proposed postsynaptic dopamine receptor in rat vas deferens.

Authors:  A Langeloh; A Jurkiewicz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

2.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

3.  Direct inhibitory effects of some 'calcium-antagonists' and trifluoperazine on the contractile proteins in smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

4.  An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice.

Authors:  Johannes Grosse; Attila Braun; David Varga-Szabo; Niklas Beyersdorf; Boris Schneider; Lutz Zeitlmann; Petra Hanke; Patricia Schropp; Silke Mühlstedt; Carolin Zorn; Michael Huber; Carolin Schmittwolf; Wolfgang Jagla; Philipp Yu; Thomas Kerkau; Harald Schulze; Michael Nehls; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.